Specimen Procedures
Breath Testing
Gut Fermentation Markers, SIBO Evaluation, and H. pylori Detection
Overview
Breath testing is a non-invasive diagnostic method used to assess various gastrointestinal conditions by analyzing gases exhaled from the lungs. This includes tests for small intestinal bacterial overgrowth (SIBO), carbohydrate malabsorption (such as lactose or fructose intolerance), and Helicobacter pylori (H. pylori) infection. The underlying principle is that specific metabolic processes or bacterial activities in the gut produce gases that are absorbed into the bloodstream and subsequently expelled through the breath.
For SIBO and carbohydrate malabsorption, the hydrogen breath test (HBT) measures hydrogen and methane levels. Patients typically undergo a preparatory phase involving dietary restrictions and avoidance of certain medications (antibiotics, probiotics, laxatives, antacids, prokinetics) for several days to weeks prior to the test. On the day of the test, after an overnight fast, a baseline breath sample is collected. The patient then ingests a specific sugar solution, with subsequent breath samples collected at regular intervals (15–30 minutes) over two to three hours.
The H. pylori breath test — specifically the urea breath test (UBT) — detects the presence of H. pylori bacteria in the stomach. The procedure involves collecting a baseline breath sample, followed by ingestion of a special liquid containing urea labeled with a carbon isotope (¹³C or ¹⁴C). After approximately 15 minutes, a second breath sample is collected. H. pylori bacteria produce the enzyme urease, which breaks down the ingested urea into carbon dioxide and ammonia. An increase in labeled carbon dioxide in the second breath sample indicates an active H. pylori infection.
Clinical Rationale
Breath testing plays a crucial role in identifying several gastrointestinal conditions. The hydrogen and methane breath tests are primarily utilized to diagnose small intestinal bacterial overgrowth (SIBO), a condition where an excessive amount of bacteria — typically found in the colon — colonize the small intestine. SIBO can cause a variety of symptoms, including bloating, abdominal pain, diarrhea, and malabsorption of nutrients. It is frequently associated with irritable bowel syndrome (IBS), and identifying SIBO as an underlying cause can guide targeted treatment strategies.
Breath tests are also used to diagnose carbohydrate malabsorption syndromes, including lactose intolerance, fructose malabsorption, sucrose intolerance, and sorbitol malabsorption. These conditions arise when specific carbohydrates are not properly digested and absorbed in the small intestine, leading to their fermentation by colonic bacteria and the production of gas. Breath testing is also instrumental in the diagnosis of Helicobacter pylori infection — a bacterium known to cause chronic gastritis, peptic ulcers, and a significant risk factor for gastric cancer. The urea breath test provides a highly accurate and non-invasive method for detecting active H. pylori infections, both for initial diagnosis and for confirming eradication after treatment.
Key Biomarkers
| Biomarker | Clinical Significance |
|---|---|
| Hydrogen (H₂) | Primary gas produced by anaerobic bacteria during fermentation of undigested carbohydrates; elevated levels indicate SIBO or carbohydrate malabsorption |
| Methane (CH₄) | Produced by methanogenic archaea; high levels indicate intestinal methanogen overgrowth (IMO); associated with constipation-predominant IBS |
| Carbon Dioxide (¹³CO₂) | Key biomarker in H. pylori urea breath test; increase after ¹³C-labeled urea ingestion signifies active H. pylori urease activity |
| Hydrogen Sulfide (H₂S) | Emerging biomarker produced by sulfate-reducing bacteria; not measured by most commercial tests; may explain "flat-line" breath test results |
| Lactulose | Non-absorbable substrate used in SIBO breath tests; early fermentation indicates bacterial overgrowth in the small bowel |
| Glucose | Rapidly absorbed substrate; fermentation in the small intestine before absorption indicates SIBO |
| Fructose | Substrate for fructose malabsorption testing |
| Lactose | Substrate for lactose intolerance testing; malabsorption leads to fermentation and gas production |
| Sucrose | Substrate for sucrose intolerance testing |
| Sorbitol | Sugar alcohol substrate for sorbitol malabsorption testing |
Evidence Base
Pimentel et al. (2020) in the American Journal of Gastroenterology (ACG Clinical Guideline) recommend breath testing (glucose hydrogen or lactulose hydrogen) for the diagnosis of SIBO in patients with IBS and in symptomatic patients with suspected motility disorders. A rise in exhaled hydrogen of at least 20 ppm above baseline within 90 minutes is diagnostic of SIBO. Rezaie et al. (2017) in the North American Consensus established standardized protocols for hydrogen and methane-based breath testing, including that a methane level of ≥10 ppm is considered positive for methane-producing organisms.
Ferwana et al. (2015) in a meta-analysis in the World Journal of Gastroenterology concluded that the urea breath test is a highly accurate and reliable non-invasive test with high sensitivity and specificity, recommended as a first-line diagnostic tool for H. pylori. Shah et al. (2010) in a meta-analysis found a significantly higher prevalence of abnormal breath tests in individuals with IBS compared to healthy controls, supporting the clinical utility of breath testing in the diagnostic workup of IBS patients. Ghoshal et al. (2017) in Gut and Liver highlighted that diagnosing and treating SIBO can lead to significant symptom improvement in a subset of IBS patients.
Limitations and Caveats
For SIBO breath tests, false negatives can occur if the bacterial overgrowth does not produce hydrogen or methane (e.g., hydrogen sulfide producers, which are not typically measured). False positives can arise from rapid transit of the substrate to the colon, leading to early fermentation and gas production that mimics SIBO. In H. pylori breath tests, recent use of antibiotics, bismuth compounds, or proton pump inhibitors (PPIs) can suppress H. pylori activity, leading to false-negative results. Patients must discontinue these medications for a specified period before testing.
Patient preparation is critical for accurate results. Failure to adhere to dietary restrictions and fasting guidelines before SIBO breath tests can lead to false positives due to fermentation of residual food in the gut. There has also been variability in the methodologies and interpretation criteria for SIBO breath tests across different studies and clinical practices. Approximately 15–30% of individuals may have gut bacteria that predominantly produce methane rather than hydrogen — measuring both hydrogen and methane is crucial for a more complete assessment.
Clinical Note